1. Home
  2. NPK vs DRUG Comparison

NPK vs DRUG Comparison

Compare NPK & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Presto Industries Inc.

NPK

National Presto Industries Inc.

HOLD

Current Price

$126.47

Market Cap

890.2M

Sector

Industrials

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$83.39

Market Cap

856.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPK
DRUG
Founded
1905
2019
Country
Employees
N/A
N/A
Industry
Ordnance And Accessories
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
890.2M
856.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NPK
DRUG
Price
$126.47
$83.39
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$106.75
AVG Volume (30 Days)
76.4K
120.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.79%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$77.63
$23.18
52 Week High
$137.78
$123.75

Technical Indicators

Market Signals
Indicator
NPK
DRUG
Relative Strength Index (RSI) 55.54 54.94
Support Level $119.22 $74.21
Resistance Level $137.78 $78.34
Average True Range (ATR) 4.58 5.59
MACD -1.33 0.22
Stochastic Oscillator 35.76 88.54

Price Performance

Historical Comparison
NPK
DRUG

About NPK National Presto Industries Inc.

National Presto Industries Inc has an eclectic product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments namely Defense, Housewares/Small Appliance, and Safety. The defense segment which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases; performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances; the safety segment provides safety technology empowering organizations and individuals to protect what is more important.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: